GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Qilian International
Shares of Qilian, a small Chinese pharmaceutical company, are extremely volatile. Their price is driven not by fundamentals, but by speculative interest and news about its products based on traditional Chinese medicine.
Share prices of companies in the market segment - Pharma other
Qilian International is a Chinese company that produces and sells traditional Chinese medicines and chemical fertilizers. We classified it as "Other Pharmaceuticals." The chart below shows how investors value companies with diversified businesses in China.
Broad Market Index - GURU.Markets
Qilian International is a Chinese company that produces and sells traditional Chinese medicines and chemical fertilizers. We classified it as "Other Pharmaceuticals." The chart below shows how investors value companies with diversified businesses in China.
Change in the price of a company, segment, and market as a whole per day
QLI - Daily change in the company's share price Qilian International
The daily price change of Qilian International Holding, a Chinese pharmaceutical company, reflects market volatility. The indicator demonstrates sensitivity to demand for its products and changes in healthcare regulations.
Daily change in the price of a set of shares in a market segment - Pharma other
Qilian International is a Chinese pharmaceutical company that produces traditional Chinese medicines and other pharmaceuticals. This market has its own specifics and regulations. The chart below shows the volatility in the pharmaceutical sector, allowing one to assess QLI's exposure to industry risks.
Daily change in the price of a broad market stock, index - GURU.Markets
Qilian International is a Chinese pharmaceutical company. Its US-traded shares are a barometer of the state of China's healthcare system and pharmaceutical market. Their dynamics add an international dimension to the overall volatility picture.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Qilian International
For Qilian International Holding, year-on-year performance tells the story of its performance in the Chinese pharmaceutical and chemical markets. Its market capitalization change over the past 12 months reflects its success in producing and selling its products, as well as its ability to adapt to the changing regulatory environment and competition in China.
Annual dynamics of market capitalization of the market segment - Pharma other
Qilian is a Chinese pharmaceutical company. Its performance is inextricably linked to the health of the Chinese economy and the country's healthcare system. This chart shows how these China-specific factors, government policy, and competition in a vast but complex market impact its performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Qilian International, a Chinese pharmaceutical company, reflects the unique dynamics of China's healthcare system. Its performance depends on the inclusion of drugs in state lists, pricing policies, and competition in a vast but strictly regulated market, creating a unique trajectory.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Qilian International
Qilian is a Chinese pharmaceutical company. Its monthly performance reflects domestic demand for its products, as well as government policies on drug pricing and procurement, which significantly impact profitability.
Monthly dynamics of market capitalization of the market segment - Pharma other
Qilian International is a Chinese company that produces and sells traditional Chinese medicines, chemicals, and fertilizers. The chart below shows the overall dynamics of the pharmaceutical sector, reflecting the specifics and opportunities of the traditional medicine market in China.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Chinese pharmaceutical stocks follow the rhythm of their local healthcare systems and regulations. The chart below shows the dynamics of global markets. How does Qilian International's path differ from this general trend?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Qilian International
The weekly performance of Qilian International, a Chinese pharmaceutical company, reflects the state of healthcare in China. Its stock price responds to demand for its products, regulatory changes, and the overall economic situation in the country.
Weekly dynamics of market capitalization of the market segment - Pharma other
Qilian International is a Chinese manufacturer of traditional medicines and chemicals. Its business depends on Chinese demand and the regulatory environment. This chart compares its performance with the pharmaceutical sector to assess how it is impacted by the specific risks and opportunities of the Chinese market.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Qilian International is a Chinese pharmaceutical company. Its stock is dependent on both the success of its products and the regulatory environment in China. This chart will help you understand what influences Qilian more: general market sentiment or the specific risks and opportunities of the Chinese market.
Market capitalization of the company, segment and market as a whole
QLI - Market capitalization of the company Qilian International
Qilian's market capitalization tells the story of a Chinese manufacturer of traditional medicines and chemicals. Its volatile chart on the US stock exchange tells a story not only about its business but also about the transparency and corporate governance risks that investors factor into the valuation of many small Chinese companies.
QLI - Share of the company's market capitalization Qilian International within the market segment - Pharma other
Qilian International is a Chinese manufacturer of traditional medicines and fertilizers. Its share of its segment's market capitalization is small, reflecting its regional focus. The chart illustrates how its share depends on domestic demand in China and the specifics of the local market.
Market capitalization of the market segment - Pharma other
Qilian International is a Chinese pharmaceutical company. The chart below shows the total market capitalization of this vast but highly regulated sector. Its dynamics reflect both the needs of China's aging population and government healthcare policies.
Market capitalization of all companies included in a broad market index - GURU.Markets
Qilian International is a Chinese pharmaceutical company. Its market capitalization reflects the state of China's vast healthcare market. Its performance on the overall chart provides a window into the development of the pharmaceutical industry in the world's second-largest economy, which has implications for everyone.
Book value capitalization of the company, segment and market as a whole
QLI - Book value capitalization of the company Qilian International
Qilian International's book value is derived from its factories in China producing traditional Chinese medicines, fertilizers, and chemicals. This represents real, diversified production capital operating in the domestic market. How has this unique Chinese asset changed? The chart below shows its dynamics.
QLI - Share of the company's book capitalization Qilian International within the market segment - Pharma other
Qilian International is a Chinese pharmaceutical company that produces licorice-based and other herbal products. The chart shows the share of its production assets, reflecting the physical scale of its traditional medicine business.
Market segment balance sheet capitalization - Pharma other
Qilian, a Chinese pharmaceutical company, operates a capital-intensive business. It requires owning factories to manufacture its products. The BCap_Seg chart for the pharmaceutical sector shows that ensuring quality and scale requires a substantial material base.
Book value of all companies included in the broad market index - GURU.Markets
Qilian's balance sheet represents its production facilities in China for heparin, licorice, and other pharmaceutical and food ingredients. The company's assets reflect its production base. The chart provides an overview of this Chinese manufacturer's global scale.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Qilian International
Qilian International is a Chinese pharmaceutical company. Its balance sheet reflects the value of its production capacity. Its market capitalization is an assessment of its product portfolio and ability to compete in China's vast domestic market. The chart shows how investors assess its position in the local healthcare system.
Market to book capitalization ratio in a market segment - Pharma other
Qilian International is a Chinese pharmaceutical company producing traditional Chinese medicine. Its market valuation on the chart reflects both its domestic business and the high risks and investor mistrust of Chinese companies listed in the US.
Market to book capitalization ratio for the market as a whole
Qilian International Holding, a Chinese pharmaceutical company, combines manufacturing assets and R&D. Its valuation depends on the domestic market and the success of its drugs. This chart helps understand how the market values international companies compared to the overall trend, driven primarily by American giants.
Debts of the company, segment and market as a whole
QLI - Company debts Qilian International
Qilian International, a Chinese pharmaceutical company, uses capital to manufacture and distribute its products, including traditional Chinese medicines. This chart shows how the company manages its finances amid strict regulatory requirements and competition in China's vast pharmaceutical market.
Market segment debts - Pharma other
Qilian International is a Chinese pharmaceutical company producing traditional Chinese and chemical medicines. This chart shows how the company finances its production and R&D, and how its debt policy compares with other players in China's highly regulated pharmaceutical market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Qilian International
Qilian International is a Chinese pharmaceutical company specializing in the production of traditional and chemical medicines. This chart shows how the company uses debt to finance its production and research, which helps assess its financial stability in the complex and regulated Chinese pharmaceutical market.
Market segment debt to market segment book capitalization - Pharma other
Qilian International is a Chinese company that produces and sells traditional Chinese medicines and fertilizers. It's a diversified business with its own unique characteristics. The chart shows general debt trends in the sector, which may provide some insight into how the company finances its diverse operations.
Debt to book value of all companies in the market
Qilian International, a Chinese company producing traditional medicines and fertilizers, operates in sectors with regional specificities. This chart, showing global debt trends, provides an interesting backdrop. It allows us to assess how the company's financial strategy aligns with the specifics of its local markets and differs from global industrial and pharmaceutical companies.
P/E of the company, segment and market as a whole
P/E - Qilian International
Qilian International is a Chinese pharmaceutical company that produces and sells traditional Chinese medicines and chemicals. This chart shows how the market views its position in the Chinese healthcare market. The dynamics reflect competition, the regulatory environment, and demand for its products.
P/E of the market segment - Pharma other
Pharmaceuticals in China, which Qilian likely operates in, are a huge but risky market. This chart shows the average valuation for pharmaceutical companies. It helps to understand that such companies are valued based on both huge domestic demand and intense competition, government pricing pressure, and regulatory risks.
P/E of the market as a whole
Qilian International is a Chinese pharmaceutical company. Its valuation depends far more on China's healthcare system and its ability to win contracts than on global market sentiment. This timeframe is less important to the company than Beijing's regulatory policies in the medical sector and competition in the domestic market.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Qilian International
The chart from Qilian International Holding Group, a Chinese pharmaceutical company, shows market expectations for future revenue. It reflects analysts' forecasts for domestic demand for its products, including lycopene and traditional Chinese medicines.
%20P%2FE%20Qilian%20International&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Qilian-International&v=1772663803939 "Chart of the company's future (projected) P/E Qilian International")
Future (projected) P/E of the market segment - Pharma other
Qilian International is a Chinese pharmaceutical company that produces and distributes traditional Chinese medicines, as well as chemicals such as heparin and licorice. The chart shows forecasts for the pharmaceutical industry. This helps assess the market's perception of Qilian's prospects, which depend on the regulatory environment and demand for its products in China.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-other&v=1772663803975 "Future (projected) P/E graph of the market segment - Pharma other")
Future (projected) P/E of the market as a whole
Qilian International Holding Group is a Chinese pharmaceutical company. Its valuation on the US stock exchange depends on its performance in the domestic market and investor sentiment toward Chinese stocks. This chart, showing the overall risk level in the US market, influences investor willingness to invest in such specific and risky assets.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772663804016 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Qilian International
Qilian International is a Chinese pharmaceutical company producing lycopene, antibiotics, and other drugs. Its profitability depends on production volumes and prices on the domestic Chinese market. This chart reflects the specifics and regulatory environment of China's pharmaceutical sector.
Profit of companies in the market segment - Pharma other
Qilian International is a Chinese pharmaceutical company producing traditional Chinese medicines and chemicals. This chart, reflecting profitability in the pharmaceutical sector, demonstrates a unique blend of tradition and modernity. Their success depends on their ability to maintain quality and meet regulatory requirements in both domestic and international markets.
Overall market profit
Qilian International is a Chinese pharmaceutical company specializing in the production of traditional Chinese medicines and chemicals. Its success depends on domestic demand and the regulatory environment. The company's performance is weakly correlated with the profitability of American corporations, as reflected in this chart, and is determined by local factors.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Qilian International
Qilian International is a Chinese pharmaceutical company that produces and markets licorice-based products, as well as other traditional Chinese medicines and fertilizers. This chart shows analysts' estimates of the company's domestic market growth and its ability to diversify its business.
%20profit%20of%20the%20company%20Qilian%20International&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Qilian-International&v=1772663804070 "Graph of future (projected) profit of the company Qilian International")
Future (predicted) profit of companies in the market segment - Pharma other
Qilian International is a Chinese pharmaceutical company that produces and distributes traditional Chinese medicines and chemicals. Its success depends on demand for its products in the domestic market. This chart for the pharmaceutical sector provides general context, but for Qilian, the specific conditions and regulatory environment in China are more important.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-other&v=1772663804074 "Graph of future (predicted) profits of companies in a market segment - Pharma other")
Future (predicted) profit of the market as a whole
Qilian International is a Chinese pharmaceutical company. Its business is dependent on healthcare costs and the economic situation in China. This graph, reflecting global expectations, impacts the Chinese economy and, consequently, the financial capacity of the healthcare system and consumers in the country.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772663804096 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Qilian International
Qilian International is a Chinese pharmaceutical company that produces lycopene, heparin, and other drugs. The chart shows how investors view its revenue. It reflects demand for its products in both domestic and international markets, as well as the risks and opportunities associated with operating in the Chinese pharmaceutical industry.
P/S market segment - Pharma other
Qilian International is a Chinese pharmaceutical company specializing in the production of traditional Chinese medicines and other pharmaceuticals. The company's revenue depends on domestic demand for its products. This chart, which displays average valuations in the sector, helps understand how investors view the company's prospects within China's unique healthcare system.
P/S of the market as a whole
Qilian International is a Chinese pharmaceutical company engaged in the production and sale of traditional Chinese medicines and chemicals. This chart, which displays the overall market revenue valuation, helps understand how investors value the company operating in China's highly regulated pharmaceutical market.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Qilian International
Qilian International is a Chinese pharmaceutical company specializing in the production and sale of licorice-based products, as well as other medicinal products. Its business is focused on the domestic market. This chart reflects investor expectations regarding future demand for its products in China and its ability to expand its product portfolio.
%20P%2FS%20Qilian%20International&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Qilian-International&v=1772663804150 "The graph of the company's future (projected) P/S Qilian International")
Future (projected) P/S of the market segment - Pharma other
Qilian International Holding Group Limited is a Chinese company engaged in the production and sale of traditional Chinese medicine, chemical pharmaceuticals, and fertilizers. This chart reflects average revenue expectations for the pharmaceutical and chemical sectors. It provides an insight into the market's perception of Qilian's diversified business prospects.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20other&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-other&v=1772663804164 "Future (projected) P/S market segment graph - Pharma other")
Future (projected) P/S of the market as a whole
Qilian International is a Chinese company engaged in the production and sale of traditional Chinese medicines, chemicals, and fertilizers. This chart shows the market's collective expectations for future revenue. The company's diversified business makes it sensitive to the state of both the healthcare and agricultural sectors in China.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772663804200 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Qilian International
This chart illustrates the revenue of Qilian International, a Chinese company that produces and sells pharmaceuticals, including those based on traditional Chinese medicine, and chemical products. Sales reflect demand for its products in the Chinese domestic market and its ability to expand its distribution network.
Sales of companies in the market segment - Pharma other
Qilian International Holding is a Chinese company engaged in the production and sale of licorice, licorice, and other traditional Chinese medicines. This chart reflects the dynamics of the traditional medicine market. The company's activities reflect the growing demand for natural and herbal products both in China and globally.
Overall market sales
Qilian International is a Chinese pharmaceutical company specializing in traditional medicine and chemicals. Its growth depends on demand in the domestic healthcare market. This total revenue chart reflects rising incomes in China, which is increasingly spending on healthcare and medications.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Qilian International
Qilian International is a Chinese company engaged in the production and sale of traditional Chinese medicines and fertilizers. Future revenue depends on demand for its products in the Chinese domestic market. The chart reflects analyst expectations for these two distinct sectors.
%20sales%20of%20the%20company%20Qilian%20International&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Qilian-International&v=1772663804276 "Schedule of future (projected) sales of the company Qilian International")
Future (projected) sales of companies in the market segment - Pharma other
Qilian International Holding is a Chinese pharmaceutical company engaged in the production and sale of traditional Chinese medicine and chemicals. This chart shows the forecast for the entire pharmaceutical market, where Qilian operates at the intersection of traditional and modern approaches to treatment.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-other&v=1772663804324 "Schedule of future (projected) sales of companies in the market segment - Pharma other")
Future (projected) sales of the market as a whole
Qilian International is a Chinese pharmaceutical company that produces traditional Chinese medicines and chemicals. Its success depends on domestic demand and the regulatory environment in China. This global trends chart has limited impact on the company, whose prospects are determined by the state of the Chinese healthcare system.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772663804334 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Qilian International
Qilian International is a Chinese pharmaceutical company specializing in the production of traditional and modern medicines. Its profitability depends on production volume, distribution, and demand for its products in the Chinese domestic market. This chart shows the financial results of the company, which operates in China's vast but highly specialized healthcare sector.
Market segment marginality - Pharma other
Qilian International is a Chinese pharmaceutical company engaged in the production and sale of traditional Chinese medicines, chemicals, and fertilizers. Profitability depends on demand for its diversified products and production efficiency. This chart shows its operating results. A comparison with the sector allows for an assessment of its unique business mix.
Market marginality as a whole
Qilian International is a Chinese company that produces and sells licorice-based products and fertilizers. Licorice is used in medicine and the food industry. This overall profitability chart is important to them because it reflects the overall health of the Chinese economy, which impacts both demand for their pharmaceutical products and the agricultural sector.
Employees in the company, segment and market as a whole
Number of employees in the company Qilian International
Qilian International is a Chinese company producing fertilizers and pharmaceuticals. Its headcount directly reflects its production capacity. This chart shows the scale of its operations in two different, but related, chemical industries.
Share of the company's employees Qilian International within the market segment - Pharma other
Qilian International is a Chinese company engaged in the production and distribution of pharmaceutical and chemical products. This chart reflects its domestic production scale. It shows the size of the team involved in the production of products such as sodium heparin and licorice-based preparations, which are the core of its business.
Number of employees in the market segment - Pharma other
Qilian International Holding Group Ltd is a Chinese company engaged in the production and sale of traditional Chinese medicines, chemicals, and fertilizers. This chart reflects employment trends in China's diversified chemical and pharmaceutical sector. The growth in personnel may be related to increased demand for the company's products in both domestic and international markets.
Number of employees in the market as a whole
Qilian International Holding is a Chinese pharmaceutical company. Its success depends on the Chinese domestic market. Global economic trends, reflected in this chart, have an indirect impact through global trade and investment flows, which influence the overall economic situation in China and, consequently, the healthcare sector.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Qilian International (QLI)
Qilian International is a Chinese pharmaceutical company that produces traditional Chinese medicines and chemicals. It is a manufacturing business. The chart shows how the market values its production assets (factories) and product portfolio. The cost per employee in pharmaceutical manufacturing reflects the level of automation, the complexity of the drugs produced, and their margins.
%20of%20the%20company%20Qilian%20International%20(QLI)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Qilian-International-QLI&v=1772663804709 "Chart of market capitalization per employee (in thousands of dollars) of the company Qilian International (QLI)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma other
Qilian International is a Chinese company engaged in the production and sale of pharmaceutical products, primarily based on lycoris and ox gallstone. This chart shows the market valuation of its production capacity and position in the domestic traditional medicine and pharmaceutical market per employee.
%20by%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-other&v=1772663804750 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma other")
Market capitalization per employee (in thousands of dollars) for the overall market
Qilian International is a Chinese pharmaceutical company producing traditional Chinese medicines. The chart shows its valuation in a specific niche of the pharmaceutical industry. It reflects how its market value, based on local brands and production capacity, compares to its team operating in the domestic market.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772663804774 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Qilian International (QLI)
Qilian International is a Chinese company that produces and markets a wide range of pharmaceuticals, including traditional Chinese medicine, chemicals, and fertilizers. It is a diversified manufacturing business. This chart shows the total profitability of their factories and their ability to sell their products in the Chinese market.
%20Chart%20Qilian%20International%20(QLI)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Qilian-International-QLI&v=1772663804808 "Company Profit Per Employee (in thousands of dollars) Chart Qilian International (QLI)")
Profit per employee (in thousands of dollars) in the market segment - Pharma other
Qilian International is a Chinese company producing traditional Chinese medicines, chemicals, and fertilizers. This indicator is a "mixed" one, reflecting the profitability of these very different and unrelated production lines.
%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-other&v=1772663804826 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma other")
Profit per employee (in thousands of dollars) for the market as a whole
Qilian International is a Chinese pharmaceutical company that produces traditional Chinese medicines and chemicals. It is a hybrid pharmaceutical/chemical business. This chart shows how efficient their production (margin) is within the Chinese market and the demand for their traditional products.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772663804841 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Qilian International (QLI)
Qilian International is a Chinese company engaged in the production and sale of traditional Chinese medicines and chemical fertilizers. This chart reflects the performance of its diversified business. The indicator's dynamics depend on demand for both pharmaceutical and agricultural products.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Qilian-International-QLI&v=1772663804850 "Sales chart per company employee Qilian International (QLI)")
Sales per employee in the market segment - Pharma other
Qilian International (QLI) is a diversified Chinese company. They produce traditional Chinese medicines (TCM), as well as chemicals and fertilizers. This chart shows the combined revenue per employee across all of these diverse segments. This measures the holding's overall production and commercial efficiency.
Sales per employee for the market as a whole
Qilian International (QLI) is a Chinese company engaged in the production and distribution of traditional Chinese medicine (TCM) and fertilizers. It is a hybrid of pharmaceuticals and chemical manufacturing. This chart shows how effectively the company utilizes its production staff and sales team to generate revenue in the domestic Chinese market.
Short shares by company, segment and market as a whole
Shares shorted by company Qilian International (QLI)
Qilian International is a Chinese company engaged in the production of traditional Chinese medicines and chemicals. The bearish sentiment shown in this chart is likely due to deep investor skepticism regarding the transparency of reporting and the true scale of many small Chinese companies listed in the US.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Qilian-International-QLI&v=1772663804955 "Short Shares Chart for the Company Qilian International (QLI)")
Shares shorted by market segment - Pharma other
This chart shows the overall investor sentiment toward the specialty pharmaceuticals segment. Qilian International focuses on the production of oxoglutarate and other products. For companies operating at the intersection of chemicals and pharmaceuticals, industry skepticism is often linked to pricing pressure or regulatory barriers, which is reflected in this indicator.
Shares shorted by the overall market
Qilian is a Chinese pharmaceutical company. This chart shows the overall market pessimism. For investors, this poses a dual risk: fear of a slowing Chinese economy and strict government regulation (VBP), which puts pressure on drug prices, eating into margins. In the panic, capital flees such risky jurisdictions.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Qilian International (QLI)
Qilian International is a Chinese pharmaceutical company that produces heparin, licorice, and other medications. Shares of Chinese healthcare companies can be volatile due to regulatory risks and competition. This indicator shows sentiment extremes: "overbought" (above 70) or "oversold" (below 30).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Qilian-International-QLI&v=1772663805064 "RSI 14 indicator chart for the company's stock Qilian International (QLI)")
RSI 14 Market Segment - Pharma other
Qilian International is a Chinese company specializing in the production and distribution of traditional Chinese medicine (TCM), as well as other chemicals and fertilizers. This chart reflects the overall sentiment in the pharmaceutical sector and helps assess how the market views the industry.
RSI 14 for the overall market
Qilian (QLI), a Chinese pharmaceutical company, sees a dual risk in this chart: economics and geopolitics. In euphoria, investors are willing to invest in "growth" and China. In panic, capital flees Chinese stocks (due to regulators), and (during a recession) demand for its products falls.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast QLI (Qilian International)
Qilian International (QLI) is a Chinese company specializing in the production and distribution of traditional Chinese medicines (TCMs) and chemicals. This chart shows the average 12-month forecast. It reflects analysts' speculative assessment of its ability to grow domestic sales and the risks associated with the regulatory environment in China.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-QLI-Qilian-International&v=1772663805311 "A chart showing analyst consensus forecasts for the expected stock price. QLI (Qilian International)")
The difference between the consensus estimate and the actual stock price QLI (Qilian International)
Qilian (QLI) is a Chinese pharmaceutical company specializing in generics and traditional Chinese medicine (TCM). This chart shows how the current share price differs from its "fair" value. It reflects analysts' views on the competitive generics market in China and their product portfolio.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-QLI-Qilian-International&v=1772663805462 "A chart showing the difference between the consensus forecast and the actual stock price. QLI (Qilian International)")
Analyst consensus forecast for stock prices by market segment - Pharma other
Qilian International is a Chinese chemical and pharmaceutical holding company that produces both "old" drugs (generics) and chemicals (fertilizers). This chart displays analysts' overall expectations for the *entire* pharmaceutical sector. It shows whether experts believe in the stability of the Chinese chemical industry and pharmaceutical market.
Analysts' consensus forecast for the overall market share price
Qilian International (QLI) is a Chinese company operating in two segments: traditional Chinese medicine (TCM) and chemical fertilizers. This chart shows overall risk appetite, reflecting investors' willingness to invest in volatile and opaque microcaps dependent on the health of the Chinese economy.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Qilian International
Qilian is a Chinese chemist and pharmaceutical company. Their specialty is the business-to-business production of old antibiotics (penicillin) and green chemicals (fertilizers, herbicides) for the Chinese market. This chart is a barometer of the Chinese industry. It reflects their (opaque) operations, their (low) margins, and their (high) dependence on (regulated) prices in China.
AKIMA Market Segment Index - Pharma other
Qilian International (QLI) is a Chinese pharmaceutical company. They are a diversified player, producing TCM (Traditional Chinese Medicine), chemicals, and fertilizers. This chart compares their composite index to the sector, showing how their hybrid (pharma + chemical) model outperforms their competitors.
The AKIM Index for the overall market
Qilian International is a Chinese pharmaceutical and chemical company producing traditional medicines, fertilizers, and heparin. This chart, showing the average (global/US) market performance, serves as a benchmark. It helps assess how QLI, a diversified manufacturer, compares to overall macroeconomic trends.
